𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of gemcitabine in advanced gallbladder cancer

✍ Scribed by J. Gallardo; B. Rubio; L. Orlandi; M. Fodor; M. Yañez; P. Salman; M. Ahumada

Book ID
117667532
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
326 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine in advance
Phase II trial of gemcitabine in advanced sarcomas
✍ Scott Okuno; John Edmonson; Michelle Mahoney; Jan C. Buckner; Stephen Frytak; Ev 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Abstract ## BACKGROUND Care for patients with advanced sarcomas is mainly palliative. Gemcitabine, a nucleoside antimetabolite, is an analog of deoxycytidine that has shown antitumor activity in several tumors. The aim of the current study was to determine the clinical activity of gemcitabine i

Expanded phase II trial of gemcitabine a
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
✍ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger